Pipeline. Advanced medicines that demonstrate both strong clinical performance and benefits to patients.

2 февр. 2024 г. · ... 2024. >$17B Global Sales. • $11.5B Psoriatic. Diseases. • $5.5B IBD. • Updated 2027 guidance for combined Skyrizi and. Rinvoq is $6B above.

28 мая 2024 г. · AbbVie showcases robust solid tumor pipeline at ASCO 2024 with new data from its innovative antibody-drug conjugate (ADC) platform.

9 сент. 2024 г. · AbbVie Showcases Advancement of Solid Tumor Pipeline at ESMO 2024, with New Data in Tumor Types with High Unmet Needs. AbbVie logo. News ...

ABBV-101 is a small molecule BTK degrader that is being investigated to treat B-cell malignancies.

3 июн. 2024 г. · Abbvie presented positive Phase I and II trial data for three ADC therapies, Teliso-V, ABBV-400 and ABBV-706, in solid tumour patients.

25 мар. 2024 г. · AbbVie will buy drug developer Landos Biopharma for up to $212 million as the Humira-maker aims to expand its pipeline of medicines to treat ...

24 июл. 2024 г. · The partnership allows Sionna to develop and commercialize multiple clinical-stage CF compounds from AbbVie.

5 февр. 2024 г. · AbbVie's oncology pipeline could do with a boost: its late-stage highlights consist largely of new uses for approved products, as well as the ...

2 авг. 2024 г. · Under the acquisition, AbbVie gains Cerevel's pipeline, which comprises multiple programs across several neurological and psychiatric conditions ...